In this week’s View, Dr. Eagle discusses a JACC State of the Art Review noting direct oral anticoagulants (DOACs) should not be standard treatment. He then explores various ways of guiding intervention for complex coronary lesions by optical coherence tomography (OCT) or intravascular ultrasound (IVUS). Finally, Dr. Eagle talks about a prespecified analysis of the CLEAR Outcomes Randomized Trial on the impact of bempedoic acid on total cardiovascular events.
Subscribe to Eagle’s Eye View
View all episodes
By American College of Cardiology
4.7
127127 ratings
In this week’s View, Dr. Eagle discusses a JACC State of the Art Review noting direct oral anticoagulants (DOACs) should not be standard treatment. He then explores various ways of guiding intervention for complex coronary lesions by optical coherence tomography (OCT) or intravascular ultrasound (IVUS). Finally, Dr. Eagle talks about a prespecified analysis of the CLEAR Outcomes Randomized Trial on the impact of bempedoic acid on total cardiovascular events.
Subscribe to Eagle’s Eye View
130 Listeners
325 Listeners
159 Listeners
865 Listeners
492 Listeners
32 Listeners
279 Listeners
87 Listeners
1,086 Listeners
60 Listeners
39 Listeners
185 Listeners
348 Listeners
423 Listeners
35 Listeners